Skip to main content
OpenTrials

Clinical trial condition

COVID-19

Explore clinical trials studying COVID-19. Study availability and eligibility vary by location and protocol.

4,620 public trials 206 recruiting studies
Refine in advanced search Browse all conditions

COVID-19 trial results

Completed

Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients

NCT04798053

Conditions
Arthritis, Bacterial Infections, Bacterial Infections and Mycoses, +23 more
Locations
  • CHU de Bordeaux - service de rhumatologie Bordeaux, France
  • AP-HP - Hopital Henri Mondor - service de rhumatologie Créteil, France
  • CHRU de Lille - Service de rhumatologie Lille, France
  • CHU de Montpellier - service de rhumatologie Montpellier, France
View Trial Details
Completed

Safety and Immunogenicity of NVX-CoV2705

NCT07079670

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Investigational Site Number US404 Phoenix, Arizona, United States
  • Investigational Site Number US395 Melrose Park, Illinois, United States
  • Investigational Site Number US406 Lenexa, Kansas, United States
  • Investigational Site Number US294 Lafayette, Louisiana, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

NCT06291857

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations
  • Paratus Clinical Research - Canberra - PPDS Bruce, Australian Capital Territory, Australia
  • Momentum Wellers Wellers Hill, Brisbane, Australia
  • Paratus Clinical Research - Western Sydney - PPDS Blacktown, New South Wales, Australia
  • Key Health- Bondi Junction Bondi Junction, New South Wales, Australia
View all 58 locations
View Trial Details
Completed

COVID-19 Antibody Responses In Cystic Fibrosis

NCT05074680

Conditions
COVID-19, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, +15 more
Locations
  • University Children's hospital Bern Bern, Switzerland
  • University Children's hospital, Zürich Zurich, Switzerland
View Trial Details
Completed

A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

NCT07069309

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Diablo Clinical Research, Inc. Walnut Creek, California, United States
  • Clinical Research Consulting Milford, Connecticut, United States
  • GW Vaccine Research Unit Washington D.C., District of Columbia, United States
  • The GW Medical Faculty Associates Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details

Related conditions